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Abstract
Background: Leukocyte migration is essential for effective host defense against invading pathogens and during immune
homeostasis. A hallmark of the regulation of this process is the presentation of chemokines in gradients stimulating
leukocyte chemotaxis via cognate chemokine receptors. For efficient migration, receptor responsiveness must be
maintained whilst the cells crawl on cell surfaces or on matrices along the attracting gradient towards increasing
concentrations of agonist. On the other hand agonist-induced desensitization and internalization is a general paradigm for
chemokine receptors which is inconsistent with the prolonged migratory capacity.
Methodology/Principal Findings: Chemotaxis of monocytes was monitored in response to fluorescent CCL2-mCherry by
time-lapse video microscopy. Uptake of the fluorescent agonist was used as indirect measure to follow the endogenous
receptor CCR2 expressed on primary human monocytes. During chemotaxis CCL2-mCherry becomes endocytosed as cargo
of CCR2, however, the internalization of CCR2 is not accompanied by reduced responsiveness of the cells due to
desensitization.
Conclusions/Significance: During chemotaxis CCR2 expressed on monocytes internalizes with the bound chemoattractant,
but cycles rapidly back to the plasma membrane to maintain high responsiveness. Moreover, following relocation of the
source of attractant, monocytes can rapidly reverse their polarization axis organizing a new leading edge along the newly
formed gradient, suggesting a uniform distribution of highly receptive CCR2 on the plasma membrane. The present
observations further indicate that during chemotaxis CCR2 acts as scavenger consuming the chemokine forming the
attracting cue.
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Introduction
Leukocyte migration is essential for innate and adaptive
immune responses and is mainly orchestrated by chemokines
presented in chemotactic gradients generated by target tissues
[1,2]. Binding of chemokines to their cognate chemokine receptors
expressed on leukocytes induces directional migration. Chemokine
receptors belong to the rhodopsin family of heterotrimeric G-
protein-coupled receptors (GPCRs) and elicit intracellular signals
via pertussis toxin sensitive Gi-proteins [3]. Signal amplitude and
duration depend on ligand concentration and are regulated
through receptor desensitization, phosphorylation and internali-
zation. Most of these responses require efficient coupling to Gi-
proteins and the activation of downstream signaling pathways.
Second messenger-dependent kinases, such as protein Kinase A or
C, usually desensitize receptors through transient phosphorylation
[4–6]. By contrast, GPCR kinase-mediated phosphorylation can
be pertussis toxin insensitive and leads to arrestin binding and
receptor internalization [7,8], which typically proceeds through
clathrin coated pits. However, in some cases chemokine receptor
internalization can also involve caveolin leading to the formation
of caveosomes, which then fuse with early endosomes, joining the
route of clathrin-dependent endocytosis [7,9–12]. Internalized
chemokine receptors residing on early endosomes can be directed
to recycling pathways or remain on the organelles that are
processed to late endosomes and ultimately to lysosomes where
protein degradation occurs [7].
CCR2 is an inflammatory chemokine receptor which mediates
migration of lymphocytes, neutrophils, dendritic cells and mono-
cytes/macrophages [2,13]. Several CC-chemokines bind to
human CCR2 and stimulate cell migration, such as CCL2,
CCL7, and CCL13 [14–16]. Typically CCR2-triggred responses
are sensitive to pertussis toxin treatment, such as calcium
mobilization and chemotaxis [17,18]. Bulk treatment of mono-
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cytes with CCL2 leads to phosphorylation of the C-terminus of
CCR2 and to its rapid internalization via arrestin binding and a
combination of clathrin coated pits and caveosomes [11,19].
Internalized CCR2 can be recycled to the membrane [20] or
become down regulated through lysosomal degradation [7,21].
Interestingly, in the case of CCR2 receptor internalization can be
dissociated from functional responses. In line with this it was
shown using phosphorylation-deficient mutants that CCR2
internalization is not essential for CCL2-stimulated chemotaxis
[22].
Receptor localization during cell migration appears to be cell
context dependent. It was reported that in polarized lymphocytes
chemotaxis-mediating receptors accumulate at the leading edge
[23], although this conclusion was questioned when analyzed in
transfected leukemia PBL-985 cells [24]. We have previously
shown that in transfected monocytic THP-1 cells chemotaxis-
mediating receptors remain uniformly distributed over the entire
cell perimeter [25]. In addition, using time-lapse video microscopy
we showed that migrating monocytes rapidly flip their polarization
axis when the source of attractant was relocated to the opposite site
(rear) of the cells. The rapid adaptation to the altered location of
the chemoattractant suggests that receptors remain evenly
distributed on the surface of monocytes to allow fast responsiveness
in any direction rather than concentrating at the leading edge
[25].
In the present study we addressed the question whether
endogenous chemokine receptors internalize during migration.
To visualize the dynamics of chemokine receptor localization in
primary untransfected human monocytes we used fluorescent
protein-tagged CCL2 to stimulate chemotaxis via endogenous
CCR2. Using time-lapse video microscopy we show that CCL2 is
efficiently and selectively internalized during migration by a
CCR2 mediated process. Furthermore sustained chemokine
uptake during migration is consistent with the view that CCR2
rapidly cycles from the plasma membrane to endosomal structures
deploying extracellular chemoattractant for degradation. Our
observations also indicate that chemokine receptors consume the
attractant from the surrounding medium during migration
potentially reducing the strength of the cue.
Materials and Methods
DNA constructs
Human CCL2 obtained by PCR from plasmid pBluescript-
CCL2 using primers 59-A AAA TCT AGA GCC ACC ATG AAA
GTC TCT GCC GCC CTT C-39 and 59-A AAA CTC GAG
AGT CTT CGG AGT TTG GGT TTG C-39 was subcloned in
frame with the red fluorescent protein mCherry [26] preceded by
a short linker sequence (coding for amino acids:
SGGGGSGGGGSGGGGS) which was fused to the fluorescent
protein via EcoR1 site removing the start methionine. The
construct was excised by enzymatic restriction with Xba1 (59) and
Kpn1 (39), the Kpn1 site was blunted with T4 polymerase
(NewEngland Biolabs) according to the manufacturer instructions
and the product ligated into Xba1 and Sma1 restriction sites of
pVL1392 (BD Biosciences) yielding pVL1392-CCL2-mCherry.
Baculoviruses were raised in Sf9 cells (Invitrogen, B825-01) using
the BaculoGoldTM kit (BD Biosciences) according to the manu-
facturer’s instructions and used to infect High Five cells to express
the recombinant protein.
Human CCL20 cDNA was prepared from PMA-stimulated
GM-1 cells [27] using a standard RT-PCR reaction. Briefly GM-1
cells were stimulated with 50 ng/ml PMA for 8 h, harvested and
mRNA was extracted using Trizol (Invitrogen) according to the
manufacturer’s instructions. Reverse transcription of 5 mg mRNA
was performed with SuperScriptH VILOTM cDNA Synthesis kit
(Invitrogen 11754-050). The primers 59-A AAA TCT AGA GCC
ACC ATG TGC TGT ACC AAG AGT TTG C-39 and 59-AAC
AAA CTC GAG CAT GTT CTT GAC TTT TTT ACT GAG
G-39 were used to amplify the CCL20 coding sequence (including
the signal peptide). The PCR product was restricted with XbaI
and XhoI and replaced for the CCL2 sequence in pVL11392-
CCL2-mCherry. Similarly the sequence of mCherry was replaced
with the sequence of Venus (EYFP) which was obtained by PCR
using a Venus fusion protein as template [25]. The sequence
integrity of all constructs was verified by DNA sequencing.
Purification of tagged chemokines
Baculovirus culture supernatants were filtered through 0.2 mm
Stericups (Invitrogen) to remove cell debris. After the supernatants
were adjusted to pH 7.3, S Sepharose (GE Healthcare) was added
and the suspension incubated for 3 h at 4uC under continuous
agitation. S Sepharose was collected by centrifugation, washed
with 50 mM NaCl, 20 mM NaPi pH 7.3 and bound chemokines
(visible by color) were eluted with a 1 M NaCl in a minimal
volume. Eluted proteins were subjected to gel filtration (Superdex
200 PC 30/3.2, GE Healthcare). Peak fractions containing pure
(.90%) chemokine, determined by calculating the absorbance
ratio of the fluorescent protein in the visible light and at 280 nm,
were pooled and stored at 280uC.
Cell isolation
PBMC were isolated from heparinized venous blood of healthy
volunteers by Ficoll-PaqueTM Plus (Ge-Healthcare) density gradi-
ent centrifugation as recommended by the manufacturer. Mono-
cytes were isolated from PBMC by MACS with the Monocyte
Isolation Kit II (Miltenyi) and their purity was determined by
FACS by staining the cells with anti-CD14 and anti-CD45.
Isolated Monocytes were resuspended at 0.56106/ml in RPMI
1640 supplemented with 10% fetal bovine serum (FBS, HyClone),
1% glutamax, 50 U/ml of penicillin and 50 mg/ml of streptomy-
cin (all Invitrogen). When indicated, cells were treated with
100 nM 17-hydroxy-wortmannin (HWT) or with 100 nM of the
CCR2 antagonist BMS CCR2 22 (TOCRIS Bioscience) for
30 min and assayed in the presence of the compound. Monocytes
were treated with 2 mg/ml Bordetella Pertussis toxin (List Biological
Laboratories) washed and subjected to video microscopy.
Calcium and Chemotaxis
Intracellular free calcium in monocytes was measured as
previously described [25]. Chemotaxis assays were performed in
triplicate in 48-well Boyden chambers (NeuroProbe, Gaithersburg,
MD), using 5 mm pore-sized polyvinylpyrrolidone-free polycar-
bonate membranes. Chemotaxis medium (RPMI-1640 supple-
mented with 1% FBS, 1% glutamax, Pen/Strep) containing
chemoattractants was added to the lower wells. Freshly isolated
monocytes (105 per well) in chemotaxis medium were added to the
upper wells and incubated for 60 min at 37uC in 5% CO2
atmosphere. Cells were removed from the upper part of the
membrane with a rubber policeman. Monocytes attached to the
lower side of the membrane were fixed and stained. Migrated cells
were counted in five randomly selected fields of 100-fold
magnification.
Microscopy
Laser scanning confocal microscopy was performed with a Leica
DI6000 microscope stand connected to a SP5 scan head equipped
CCL2 Uptake during Monocyte Migration
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with a temperature controlled chamber. If not indicated separately
videos were routinely recorded with a 636 objective. Live cell
cultures were placed in a humidified air/CO2-controlled incubator
which was mounted on the microscope stage. For time-lapse video
microscopy cells (0.56106/ml) were resuspended in D-PBS
containing Ca2+and Mg2+ (Invitrogen) supplemented with 1%
FBS, 1% Pen/Strep, 0.04 mM sodium pyruvate, 1 mg/ml fatty
acid free BSA (Sigma), 1 mg/ml glucose. Cells were plated on
glass bottom petridishes (MatTek cultureware) coated with D-
polylysine (5 mg/ml) and subsequently overlaid with a 1:80 diluted
MatrigelH (BD Biosciences) solution at 4uC for 30 min.
Chemoattractants were dispersed with a micropipette (Femto-
tipII, Eppendorf) controlled by micromanipulator (Eppendorf) at a
constant backpressure of 15 hPa (Femtojet, Eppendorf).
Results
Responsiveness of CCR2 to CCL2 and CCL2mCherry
To monitor receptor ligand interactions in primary non-
transfected monocytes we generated a fluorescent analogue of
CCL2 by fusing the monomeric red fluorescent protein mCherry
to its C-terminus (CCL2-mCherry) [28]. Given the relative size of
the fluorescent protein moiety with respect to the chemokine we
first compared the efficiency of the fusion protein and wild type
counterpart in chemotaxis and calcium mobilization assays.
Figure 1 demonstrates that CCL2 and CCL2-mCherry possess
similar efficacy and efficiency in eliciting migration and calcium
fluxes in human monocytes. Chemotaxis was measured in Boyden
chamber assays [25] and showed the typical bell shaped dose-
response curve. Similarly, the stimulus-induced rise in intracellular
free calcium ([Ca2+]i) was similar with both forms of CCL2. The
results indicate that the fusion protein was equally potent as wild
type CCL2, suggesting that attachment of mCherry does not
interfere with receptor ligand interactions.
Human monocyte migration towards CCL2-mCherry
Leukocytes exposed to chemokine gradients rapidly polarize
forming a distinct leading edge and an uropod. The receptors
which mediate the process remain uniformly distributed over the
entire plasma membrane, but downstream signaling is polarized
leading to the activation of PI 3-kinase exclusively at the leading
edge [25]. Bulk-stimulation of leukocytes in vitro typically causes
the desensitization and subsequent internalization of the chemoat-
tractant receptors. We asked whether cells crawling along a
chemotactic gradient remain responsive to the attractant over time
allowing the continuous movement. To this end freshly isolated
human monocytes were plated on glass-bottom dishes, coated with
poly-D-lysine and a monolayer of matrigel [25], and placed in a
temperature controlled ambience fitted on a confocal microscope
stage. The attractant CCL2-mCherry was dispensed from a
micropipette with constant pressure. Time-lapse video microscopy
was recorded in the respective fluorescence channel and by phase
contrast. Figure 2A and in more detail movie S1 demonstrate that
human monocytes quickly orient toward the source of the
attractant. Ligand association over the entire cell perimeter is
observed after one minute and is followed by uptake as visualized
by the localization of mCherry fluorescence in small endosomal-
like structures. Figure 2B depicts a single plane of a confocal stack
taken at high magnification (1006) of a monocyte migrating
towards CCL2-mCherry. The right panel and movie S2 display
the 3D computer-assisted reconstruction of the stacks confirming
that mCherry is contained in intracellular structures (blue).
Migration of monocytes towards the dispensing pipette was
observed over a wide range of chemokine concentrations and
continued for prolonged time even at elevated concentrations
(10 mM, see below). However, dispensing an irrelevant chemokine
or medium alone did not cause polarization of the cells (not
shown).
Over time the endosomes become larger and accumulate
preferentially at the rear of the cells, opposite to the source of the
attractant. It is conceivable that initial small endosomes fuse to
develop the larger structures, which appear with stronger
fluorescence due to their enriched chemokine content (Fig. 2A).
Next, monocytes were allowed to migrate for 15 min towards
CCL2 and then the dispensing pipette was removed from the
medium (movie S3). After 30 min the cells had degraded all
internalized CCL2-mCherry, lost polarity completely and re-
Figure 1. CCL2-mCherry has similar potency as wild type CCL2.
Freshly isolated human monocytes chemotaxis was measured in
Boyden chamber chemotaxis assays at the indicated concentrations
(A). Wild type CCL2 (black circles) and CCL2-mCherry (red circles) was
added to the lower compartment at the indicated concentrations.
Samples from atypical experiment were determined in triplicates.
Intracellular free calcium in fura-2 loaded monocytes stimulated with
CCL2-mCherry (left traces) or wild type CCL2 (right traces). Both
chemokines gave similar responses at the indicated concentrations
(right). Individual traces from a typical experiment performed in
duplicates.
doi:10.1371/journal.pone.0037208.g001
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turned to a spherical shape similarly to the appearance of resting
cells. Nevertheless, upon reinsertion of the dispensing pipette
monocytes rapidly polarized again and migrated toward the
relocated source of chemoattractant avidly taking up CCL2-
mCherry. The observation indicates that CCR2 remains respon-
sive at the cell surface over the entire recording time, including
after removal of the chemotactic cue.
CCL2 uptake is CCR-mediated
The continuous migration toward the dispensing pipette and the
concomitant intracellular accumulation of the chemoattractant is
consistent with an active process of ligand uptake during
chemotaxis. Three possible mechanism of chemokine internaliza-
tion were considered: i) uptake by the cognate chemokine receptor
CCR2, ii) uptake through the scavenger receptor D6 which is
expressed on monocytes [29] and iii) internalization via (micro)
pinocytosis. First we investigated the possibility of receptor-
independent uptake by pinocytosis. To this end we produced
recombinant human CCL20 fused to green fluorescent protein
(CCL20-EYFP). CCL20 is a selective ligand for CCR6, which is
expressed on lymphocytes and some dendritic cells, but not on
monocytes [2]. Accordingly, neither CCL20 nor CCL20-EYFP
induced chemotaxis of monocytes (not shown). When the
dispensing pipette was filled with equal molar solutions of the
green fluorescent CCL20 and the red fluorescent CCL2,
monocytes migrated towards the source, but internalized exclu-
sively the red fluorescent CCL2 (Fig. 3 and movie S4). The movie
S4 shows the exclusive formation of red fluorescent endosomes
even in close vicinity of the orifice of the pipette where the cells are
surrounded by the green fluorescent CCL20. The images
demonstrate an efficient capacity of the monocytes to discriminate
between the two chemokines. The observation strongly argues
against a receptor-independent, random fluid uptake, excluding
pinocytosis as responsible mechanism of chemokine internaliza-
tion.
A second possibility of chemokine uptake could be mediated by
scavenger receptors. Among the known mammalian chemokine
scavenger receptors only D6 and DARC bind CCL2. The latter,
however, is not expressed on monocytes [30]. D6 is a promiscuous
receptor which binds multiple chemokines including CCL2 and
CCL22, but not CCL20. To test the possible involvement of the
scavenger receptor in chemokine uptake we used a ligand binding
competition assay. The competition assay was chosen because
antibodies that efficiently block the scavenging activity of D6 are
not available. D6 binds CCL22 with slightly higher affinity than
CCL2 [31]. Boyden chamber assays indicate that monocytes
migrate in response to both chemokines although with different
efficacies, CCL2 being more potent [32,33]. In the time-lapse
studies of chemotaxis shown in figure 4 and movie S5 the
dispensing pipette was filled with 100 nM CCL2-mCherry in the
presence of two order of magnitude larger concentration of
CCL22 (10 mM). Under these conditions binding of CCL2 to D6
should be efficiently competed by CCL22, thus essentially blocking
uptake of CCL2-mCherry. Figure 4 and movie S5 demonstrate
that monocytes rapidly polarize and migrate towards the source of
the chemoattractant. The marked internalization of CCL2-
mCherry observed during migration was comparable in the
presence or in the absence of CCL22, strongly arguing that uptake
is mediated by CCR2 and not by D6. Since chemokine uptake is
not mediated by pinocytosis or scavenger receptors it can be
concluded that during monocyte migration CCR2 internalizes and
deploys its cargo into lysosomes. This conclusion is also supported
by the observation that uptake of CCL2-mCherry (100 nM) in
migrating monocytes was markedly suppressed when administered
Figure 2. Monocytes internalize CCL2-mCherry during migra-
tion. Selected frames from time-lapse video microscopy (Movie S1) of
migrating human monocytes recorded at 37uC (A). The micropipette
was dispending 100 nM CCL2-mCherry with constant backpressure. Left
panels phase images, middle panels CCL2-mCherry (ex 594 nm/em
620–680 nm), and right overlay. Time stamps are indicated in mm:ss,
calibration bar 10 mm (top left panel). (B) Single cell recorded at higher
magnification (1006). Left plane from a confocal stack, right 3D
rendering from the stack. The endosomal surface (blue) was calculated
from the mCherry fluorescence using the Imaris software package (see
also Movie S2).
doi:10.1371/journal.pone.0037208.g002
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together with 10 mM untagged wild-type CCL2 (not shown). By
contrast, blocking CCL2 binding to CCR2 with a specific low
molecular weight antagonist (BMS CCR2 22 [34]) fully inhibited
migration and abrogated CCL2-mCherry uptake (Fig. 5 and
movie S6). The observations further corroborate that endocytosis
of the tagged chemokine is mediated by CCR2.
Reversal of the chemotactic gradient switches monocyte
polarity
We have previously shown that chemotaxis-mediating receptors
remain equally distributed over the entire plasma membrane and
that monocytes can rapidly reverse their polarization axis when
the dispensing pipette is shifted from the front to the rear of the cell
[25]. With the fluorescent chemokine in hand we were interested
to test if chemokine uptake continues upon reversal of the
gradient. Movie S7 (and Fig. 6) demonstrate that monocytes
rapidly reverse their polarization axis when the pipette is moved to
the opposite end of a polarized cell. Chemokine uptake continues
and is accompanied by the relocation of the chemokine-loaded
endosomes to the rear of the newly re-polarized cell. The movie
also shows that the process can be repeated several times with the
same outcome. This observation suggests that receptors internalize
the bound fluorescent chemokine. While the cargo is deployed to
endosomes for degradation the unloaded receptors recycle to the
cell surface to maintain the responsiveness of the cell towards the
attractant. In line with this we observed that after removal of the
pipette from the surrounding medium the internalized chemokine
is fully degraded within 15–20 min, but the cells remain responsive
to a subsequent stimulation (movie S3). The observations indicate
that chemokine receptors during migration consume the attractant
from the medium acting as scavenging receptors.
G-protein coupling is not required for chemokine uptake
Chemokine receptors in general couple to pertussis toxin
sensitive Gi proteins and therefore their functional responses are
inhibited following treatment of cells with the toxin [1]. We
preincubated monocytes with pertussis toxin to assess their
capacity to respond to CCL2-mCherry in time-lapse studies.
According to the notion that polarization depends on receptor-
induced signaling toxin-treated cells did not polarize upon
exposure to the fluorescent chemokine. Nevertheless, the cells
were vibrant, actively forming filopodia- and lammelipodia-like
protrusions, presumably triggered by pertussis toxin-independent
mechanisms. Although they did not show any tendency to migrate
Figure 3. CCL2-mCherry uptake is not due to pinocytosis.
Selected frames from time-lapse video microscopy (Movie S4) of
migrating monocytes recorded at 37uC. The micropipette was
dispending 1 mM CCL2-mCherry and 1 mM CCL20-EYFP with constant
backpressure. Left panels CCL2-mCherry (ex 594 nm/em 620–680 nm),
middle panels CCL20-EYFP (ex 488 nm/em 500–520 nm), and right
panels merged frames overlaid with the corresponding phase image.
Time stamps are indicated in mm:ss.
doi:10.1371/journal.pone.0037208.g003
Figure 4. CCL2 uptake is D6-independent. Selected frames from
time-lapse video microscopy (Movie S5) of migrating monocytes
recorded at 37uC. The micropipette was dispending 100 nM CCL2-
mCherry and 10 mM of the D6 ligand CCL22 with constant back-
pressure. Left panels phase images, middle panels CCL2-mCherry (ex
594 nm/em 620–680 nm), and right overlay. Time stamps are indicated
in mm:ss.
doi:10.1371/journal.pone.0037208.g004
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in whichever direction, pertussis toxin treated monocytes inter-
nalized the CCL2-mCherry (Fig. 7 and movie S8). The
fluorescence intensity of the endosomes increased over time
indicating that the receptors continuously internalized the
chemokine, which accumulated randomly within the cells,
consistent with the non-polarized morphology. This finding
suggests that receptor internalization is independent of cell
migration, but intracellular distribution of chemokine loaded
requires polarization.
Phosphoinositide 3-kinase activity is dispensable for cell
migration
The role of phosphoinositide 3-kinase (PI 3-kinase) in
chemokine receptor trafficking and internalization has been
debated. Inhibition of PI 3-kinase reduces the transferrin receptor
expression and cycling and perturbs endosome fusion [35]. It was
also shown that protein kinase activity of PI 3-kinase is required for
the endocytosis of the b-adrenegic receptor [36]. However, for T
lymphocytes it was reported that PI 3-kinase activity is not
required for chemokine receptor internalization [37]. Thus, these
reports do not support a consistent role of PI 3-kinase in receptor
trafficking. We therefore investigated the potential role of PI 3-
kinase in chemokine uptake during monocyte chemotaxis. Cells
were pretreated for 20 min with 100 nM of the potent irreversible
PI 3-kinase inhibitor wortmannin [38]. In previous studies and
parallel experiments it was confirmed that this experimental
regime is sufficient to fully abrogate PI 3-kinase activity (not
shown). The cells were then exposed to CCL2-mCherry as before.
Movie S9 and figure 8A show that wortmannin treated monocytes
polarize and migrate towards the dispensing pipette similarly as
untreated cells. Moreover the cells can rapidly flip their
polarization axis following displacement of the pipette. During
migration monocytes internalized continuously CCL2-mCherry,
which accumulated in endosomes, that preferentially localized at
the posterior end of the cells. Thus, inhibition of PI 3-kinase does
not impair chemokine uptake and accumulation in large
endosomes.
Inhibition of PI 3-kinase resulted in a minor change in the
migratory index (MI). The MI is indicative for the efficiency of the
cell movement representing the straightness of a migratory trace,
calculated as the quotient of the shortest distance between the
starting and the end point of a trace divided by the actual trace
length (Fig. 8B and C). Similarly the velocity of the monocytes
migration was not affected when PI 3-kinases activity was
abrogated (Fig. 8D). The finding is consistent with previous data
which unveiled that PI-3-kinase activity is dispensable for the
migration of neutrophils, the monocytic cell line THP-1 and the
amoeba Dictyostelium [25,39–41].
Figure 5. CCL2-mCherry uptake is blocked in the presence of
an CCR2 antagonist. Selected frames from time-lapse video
microscopy (Movie S6) of human monocytes recorded at 37uC in the
presence of 100 nM of the CCR2 antagonist BMS CCR2 22. The
micropipette was dispending 100 nM CCL2-mCherry with constant
backpressure. Left panels phase images, middle panels CCL2-mCherry
(ex 594 nm/em 620–680 nm), and right overlay. Time stamps are
indicated in mm:ss.
doi:10.1371/journal.pone.0037208.g005
Figure 6. CCL2-mCherry uptake continues after reversal of
polarization. Selected frames from time-lapse video microscopy
(Movie S7) of migrating human monocytes recorded at 37uC. The
micropipette was dispending 100 nM CCL2-mCherry with constant
backpressure. The position of the needle was changed several times
during recording. Left panels phase images, middle panels CCL2-
mCherry (ex 594 nm/em 620–680 nm), and right overlay. Arrows
indicate the localization of internalized CCL2-mCherry in two represen-
tative cells upon reverting their axis of polarization. Time stamps are
indicated in mm:ss.
doi:10.1371/journal.pone.0037208.g006
CCL2 Uptake during Monocyte Migration
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Discussion
In this study we investigated CCR2-mediated migration in
primary human monocytes using the fluorescent receptor agonist
CCL2-mCherry. Direct visualization of the endogenous CCR2 is
not possible in primary cells. However, given that CCR2 is the
only receptor for CCL2 expressed on monocytes, tracking the
fluorescence of CCL2-mCherry allows to deduce conclusions on
receptor-dependent cellular responses. Directional migration
requires continuous signaling from receptors localized at the
leading edge. This view is supported by the observation that upon
reversal of the chemotactic cue monocytes rapidly switch their
polarity (Fig. 6 and Movie S7 [25]) and orient the leading edge
towards the new location of the chemokine source. Hence,
receptors must be ubiquitously localized on the cell surface of
migrating cells to be able to respond to moving attracting cues.
CCR2-dependent migration of human monocytes towards the
source dispensing CCL2 is accompanied by receptor-mediated
ligand uptake. However, CCR2 internalization appears not to
reduce the responsiveness of the cells to continuously migrate
towards CCL2, suggesting that the receptors are rapidly recycled
or that sufficient non-internalized receptors are available at the cell
surface to maintain the responsiveness. In one study it was
estimated that human monocytes express at their surface about
13’000 binding sites for CCL2 with relatively low affinity (Kd
25 nM) for the agonist [42]. However, other reports indicate a
lower number (1200–1700) of high affinity (Kd 1–2 nM) binding
sites for CCL2 [43,44] and the high affinity binding of CCL2 on
CCR2 was recently confirmed [32,45], supporting the estimation
of the lower receptor numbers. From our time-lapse video images
we measured an average diameter of resting monocytes (e.g.
Fig. 2A, movie S1) of 8.8732 mm (n= 28, from 14 cells measured
on 2 perpendicular axes). Assuming a spherical shape of resting
Figure 7. Pertussis toxin does not inhibit CCL2 uptake. Selected
frames from time-lapse video microscopy (Movie S8) of migrating
human monocytes recorded at 37uC. Monocytes were pretreated with
2 mg/ml Bordetella Pertussis toxin (PTX) for 2 h. The micropipette was
dispending 100 nM CCL2-mCherry with constant backpressure. Left
panels phase images, middle panels CCL2-mCherry (ex 594 nm/em
620–680 nm), and right overlay. Inset of bottom right panel, zoomed
presentation of the same cells showing randomly localized internalized
CCL2-mCherry. Time stamps are indicated in mm:ss.
doi:10.1371/journal.pone.0037208.g007
Figure 8. Inhibition of PI 3-kinase does not affect CCL2 uptake
and monocyte migration. (A) Selected frames from time-lapse video
microscopy (Movie S9) of migrating human monocytes recorded at
37uC. Monocytes were pretreated with 100 nM wortmannin for 30 min.
The micropipette was dispending 100 nM CCL2-mCherry with constant
backpressure. Gray (left column) corresponding phase image. Left
panels phase images, middle panels CCL2-mCherry (ex 594 nm/em
620–680 nm), and right overlay. Time stamps are indicated in mm:ss. (B
and C) Analysis of directionality and velocity of monocytes: effect of PI
3-kinase inhibition. Tracks of monocytes (recorded as in Fig. 1 or Fig. 8A)
either untreated (B) or pretreated with 100 nM wortmannin (C) were
analyzed and plotted aligning their average directional vector with the
y-axis (distance in mm). (D) Mean velocity of tracks shown in (B) and (C)
were calculated using Metamorph software and median speed (MS)
values are reported. Data from two independent observations, n = 16
(A) and n= 15 (B). MI =migratory index is the distance between the
starting point and the end point divided by the total migrated distance.
doi:10.1371/journal.pone.0037208.g008
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cells the calculated average surface area is ,250 mm2, with
approximately 5–10 receptor molecules per mm2. Thus, the
number of CCR2 molecules facing the chemokine source is
limited. Because CCL2 is most probably endocytosed as cargo
bound to CCR2 and agonist uptake continues throughout
migration, we conclude that receptor internalization must be
compensated by rapid recycling. It is conceivable that the average
number of receptors expressed at the monocyte surface drops
upon continuous stimulation. However, the cells must be able to
express sufficient receptors to maintain cell polarity and to mediate
directional migration. Fig. 3 and 4 (Movies 4 and 5) show that
alternative routes of chemokine uptake, such as pinocytosis or
scavenger receptor-mediated, can be excluded and that blocking
CCR2 abolishes CCL2-mChery internalization (Fig. 5 and Movie
S6). Taken together our observations indicate that CCL2 is
specifically taken up by CCR2 and that a stimulus-responsive
fraction of the receptors must be expressed at the cell surface,
supporting the conclusion that CCR2 cycles between the plasma
membrane and endosomal compartments of monocytes, thereby
consuming its ligand from the surrounding medium during
migration.
It was previously shown that CCR2 expressed on monocytes
can down regulate local chemokine levels in vivo [46]. Using CCL2
concentrations found in bronco-alveolar lavage fluids (600 pg/ml
or ,70 pM) in vitro measured CCR2-dependent consumption of
CCL2 was reported as 450 pg/ml/100’000 cells in 24 h.
Accordingly, monocytes would take up approx. 0.36 *10221
moles/min equivalent to 1 molecule/receptor in 7–8 min. The
determination is probably an underestimate of the maximum
capacity due to the low concentration of chemokine offered in the
incubation medium (,70 pM) with respect to the Kd (1–2 nM) of
CCR2 for CCL2 [46]. In the present study CCL2 was dispensed
at 100 nM from the tip of micropipette. Taking into account the
rapid dilution of the chemokine in the medium which reduces the
concentration in a crude approximation by 50% every 20–30 mm
(not shown), determinations of the chemoattractant concentration
at the leading edge remain vague, due to the non-linear flow rate
imposed by the narrow orifice of the pipette and the free diffusion
of the ligand in the medium [25]. Nevertheless, monocyte
migration can be induced with a wide range of CCL2
concentrations becoming effective at ,30 nM (and tested up to
10 mM). No migration is observed below 10 nM CCL2 or with
buffer alone. Thus, in the present experiments monocytes were
exposed to local concentrations which were close to or significantly
above Kd. At these elevated concentrations of agonist receptor
cycling is probably much higher than reported in [46] explaining
the continuous marked uptake of CCL2-mCherry during chemo-
taxis.
In general chemokine receptors when exposed in vitro to their
cognate chemokines are rapidly desensitized and become refrac-
tory to a subsequent stimulation [3]. Nevertheless, full receptor
desensitization usually requires elevated ligand concentrations, i.e.
10–100 fold Kd, as demonstrated by sequential stimulation of
calcium mobilization [14,47,48]. Similarly, bulk stimulation with
CCL2 induces the gradual internalization of CCR2, starting to be
observed already at 0.1 nM CCL2, i.e. of one order of magnitude
below Kd, being prominent around Kd and most efficient at 100
fold Kd [20,22]. Following CCL2-mediated down regulation,
CCR2 surface expression is slowly restored reaching 100% and
70% after 4 h in vivo and in vitro, respectively [20]. Nevertheless,
the newly expressed receptors were reported to be unable to
stimulate migratory responses for up to 8 h, an observation that is
in contrast with our findings [20]. First, our observations support
the conclusion that receptors undergo several rounds of cycling
between the plasma membrane and endosomes to maintain
sustained responsiveness of the cells (e.g. for up to 20 min Movie
S1). Second, monocytes stimulated for 15 min preserve their
ability to respond immediately when re-exposed to CCL2 (Movie
S3). The data suggest a qualitatively different effect on CCR2
when monocytes are stimulated in bulk, i.e. in suspension, or by
chemotactic gradients while adhering to a matrix. Importantly, in
vivo monocytes migrate being adherent to cell surfaces or matrix
proteins rather than being in suspension, suggesting that cell-cell
or cell-matrix interaction are required to observe the physiological
behavior of CCR2. Bulk stimulation of monocytes with CCL2
leads to the rapid internalization of CCR2 passing through early
and late endosomes before being degraded in lysosomes [11].
Tracking of the endocytic route in primary cells requires fixing
and staining for endosomal markers. Such experiments are
difficult to perform with the time-lapse video microscopy settings
used to study human monocytes, where only few non-firmly
adherent cells in close vicinity of the dispensing pipette migrate in
the gradient. Transduction of freshly isolated monocytes with
fluorescent-protein tagged endocytic markers is not recommended
as the cells require over 24 h before the gene of interest reaches
sufficient expression levels. During this time cultured monocytes
lose their phenotype differentiating into macrophage-like cells with
markedly different migratory properties. Tracking CCR2 could
eventually be possible when monocytes from genetically engi-
neered mice expressing fluorescent endosomal markers become
available.
It is well established that pertussis toxin treatment abolishes
monocyte migration (Fig. 5), but has no effect on arrestin
recruitment and CCR2 internalization [3,49,50]. Conversely,
CCR2 internalization can be dispensable for cell migration [22].
Mutation of serine to alanine residues in the C-terminus prevents
CCR2 phosphorylation and abolishes receptor internalization
which is mediated by a combination of clathrin-dependent and -
independent pathways [7,11,19,22]. Interestingly, at elevated
CCL2 concentrations cells expressing a phosphorylation-deficient
mutant CCR2 appear to be less efficient to migrate in Boyden
chamber assays [22]. The finding is consistent with the conclusion
that recycling (and cargo deployment) is not required per se, but
might be needed to maintain the responsiveness at higher agonist
concentrations. Our observations that CCL2-mCherry uptake
persists in pertussis toxin-treated monocytes is in agreement with
these previous reports demonstrating that toxin treatment
abolishes migration, but does not affect CCR2 internalization.
Furthermore we show that monocyte polarization and migration,
as well as chemokine uptake and endosome fusion, are not
attenuated by inhibition of PI-3kinase. The observation indicates
that in migrating cells treated with wortmannin CCR2 can cycle
between the surface and endosomal compartments. Wortmannin
is known as potent irreversible pan-PI3K inhibitor, suggesting that
PI 3-kinase activity is dispensable for signal transduction pathways
regulating ligand uptake and endosme fusion. The finding is in
agreement with the previous reported observations made in THP-
1 cells [25]. Given the constrains discussed above on the necessity
of receptor trafficking during cell migration it is reasonable to
conclude that PI 3-kinase activity is also not required for CCR2
recycling. Taken together the present data, also obtained by the
indirect measurement of fluorescent CCL2-mCherry uptake,
indicate that chemokine receptors expressed on leukocytes
internalize during chemotaxis and can act as scavengers for their
cognate chemokines. The observation adds to the complexity of
chemokine receptor signal transduction on leukocyte. The
mechanism allows the cells to proceed along an increasing
gradient of chemoattractant without being desensitized. In
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addition, consumption of the attractant represents a means by
which migrating cells can reduce the strength of a chemotactic
gradient for subsequently arriving leukocytes.
Supporting Information
Movie S1 Migration of freshly isolated human mono-
cytes stimulated with CCL2-mCherry. Frames were taken
at 5 sec interval with a 636magnification. Cells were stimulated
with 100 nM CCL2-mCherry. Red fluorescence derives from the
recombinant chemokine mCherry-tagged (ex 594 nm excitation/
620-680 nm emission), phase images were taken with DIC
settings. Overlay of phase and fluorescence is shown.
(AVI)
Movie S2 Migration of freshly isolated human mono-
cytes stimulated with CCL2-mCherry. Confocal stacks (7)
were taken at 15 sec interval with a 1006 magnification. Cells
were stimulated with 100 nM CCL2-mCherry. The surface of
endosomes (blue) was calculated from the recorded red fluores-
cence CCL2- mCherry-tagged (ex 594 nm excitation/620–
680 nm emission) using Imaris software, phase images were taken
with DIC settings. Overlay of calculated surfaces and phase is
shown.
(AVI)
Movie S3 Migration of freshly isolated human mono-
cytes stimulated with CCL2-mCherry. Frames were taken
at 5 sec interval with a 636magnification. Cells were stimulated
with 100 nM CCL2-mCherry. The dispensing micropipette was
removed after 15 min and reinserted after 30 min. Red fluores-
cence derives from the recombinant chemokine mCherry-tagged
(ex 594 nm excitation/620–680 nm emission), phase images were
taken with DIC settings. Overlay of phase and fluorescence is
shown.
(AVI)
Movie S4 Monocyte migration stimulated in the pres-
ence of CCL2-mCherry and CCL20-EYP. Frames were
taken at 5 sec interval with a 636magnification. The stimuli were
released from a micropipette dispensing a solution containing
1 mM CCL2-mCherry and 1 mM CCL20-EYFP. The emission of
CCL2-mCherry (594 nm excitation/620–680 nm emission) and
CCL20-YFPP (488 nm exitation 500–520 nm emission) was
recorded simultaneously. Phase images were taken with DIC
settings. Overlay of phase and fluorescence is shown.
(AVI)
Movie S5 Monocyte migration stimulated in the pres-
ence of CCL2-mCherry and CCL22. Frames were taken at
5 sec interval with a 636magnification. The stimuli were released
from a micropipette dispensing a solution containing 100 nM
CCL2-mCherry and 10 mM CCL22. The emission of CCL2-
mCherry (594 nm excitation/620–680 nm emission) was overlaid
with phase images taken with DIC settings.
(AVI)
Movie S6 CCL2-mCherry uptake is fully inhibited in the
presence of 100 nM of the CCR2 antagonist BMS CCR2
22. Monocytes were pretreated with the antagonist for 10 min
before insertion of the micropipette dispending 100 nM CCL2-
mCherry. Frames were taken at 15 sec interval with a 1006
magnification. Red fluorescence derives from the recombinant
chemokine mCherry-tagged (ex 594 nm excitation/620–680 nm
emission), phase images were taken with DIC settings. Overlay of
phase and fluorescence is shown
(AVI)
Movie S7 Relocation of the attractant source has no
effect on CCL2-mCherry uptake. Frames were taken at 5 sec
interval with a 636 magnification. Cells were stimulated with
100 nM CCL2-mCherry. The position of the micropipette
dispensing 100 nM CCL2-mCherry was changed several times
during recording. The emission of CCL2-mCherry (594 nm
excitation/620–680 nm emission) was overlaid with phase images
taken with DIC settings.
(AVI)
Movie S8 CCL2-mCherry uptake is not affected by
pertusiss toxin treatment. Monocytes were pretreated with
2 mg/ml Bordetella Pertussis toxin for 2 h. The micropipette was
dispending 100 nM CCL2-mCherry. Frames were taken at 5 sec
interval with a 636magnification. Red fluorescence derives from
the recombinant chemokine mCherry-tagged (ex 594 nm excita-
tion/620–680 nm emission), phase images were taken with DIC
settings. Overlay of phase and fluorescence is shown.
(AVI)
Movie S9 Inhibition of PI 3-kinase does not affect CCL2
uptake and monocyte migration.Monocytes were pretreated
with 100 nM wortmannin for 30 min. The micropipette was
dispending 100 nM CCL2-mCherry. Red fluorescence derives
from the recombinant chemokine mCherry-tagged (ex 594 nm
excitation/620–680 nm emission), phase images were taken with
DIC settings. Overlay of phase and fluorescence is shown.
(AVI)
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